- Home
- UNCY vs BHAV Comparison
UNCY vs BHAV Comparison
Compare UNCY & BHAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
SELL
Current Price
$4.06
Company Overview
Basic Information| Metric | UNCY | BHAV |
|---|---|---|
| Founded | 2016 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.1M | 140.8M |
| IPO Year | 2021 | 2026 |
Fundamental Metrics
Financial Performance| Metric | UNCY | BHAV |
|---|---|---|
| Price | $4.06 | $10.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $28.40 | N/A |
| AVG Volume (30 Days) | ★ 802.1K | 29.6K |
| Earning Date | 11-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $675,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10,812.60 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.93 | $9.90 |
| 52 Week High | $8.74 | $10.05 |
Technical Indicators
Market Signals| Indicator | UNCY | BHAV |
|---|---|---|
| Relative Strength Index (RSI) | 29.66 | 55.75 |
| Support Level | $3.93 | $10.02 |
| Resistance Level | $5.86 | $10.05 |
| Average True Range (ATR) | 0.19 | 0.01 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 3.22 | 39.39 |
Price Performance
Historical Comparison UNCY
BHAV
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
About BHAV BHAV Acquisition Corp Class A Ordinary Shares
BHAV Acquisition Corp is a blank check company.